| Announce Date | 08/05/2025 |
| EPS Normalized Actual | $0.48 (Beat by $0.00079999999999997) |
| EPS GAAP Actual | $0.48 (Beat by $0.00079999999999997) |
| Revenue Actual | $9.246B |
| Revenue Surprise | Beat by $9246M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 10.49 | 22.26 | 9.38817 | 11.83886 | 4 |
| Dec 2028 | 10.49 | 22.26 | 8.79489 | 11.96515 | 7 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.76 | 0.76 | 9.246B | 26.25% | 9246M |
| FQ2 2025 (Jun 2025) | 0.54 | 0.54 | 7.685B | 24.07% | 7685M |
| FQ1 2025 (Mar 2025) | 0.44 | 0.44 | 7.438B | 26.42% | 7438M |
| FQ4 2024 (Dec 2024) | 0.3 | 0.3 | 7.658B | 19.46% | 7658M |
| FQ3 2024 (Sep 2024) | 0.48 | 0.48 | 6.819B | 21.41% | 6819M |
| FQ2 2024 (Jun 2024) | 0.16 | 0.16 | 5.835B | 100% | 5835M |
| FQ1 2024 (Mar 2024) | 0.0761 | 0.0761 | 5.473B | 100% | 5473M |
| FQ4 2023 (Dec 2023) | 0.41 | 0.41 | 6.168B | 9.23% | 6168M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 3.2934 | -- | 3.0961 | 3.51939 | 15 |
| FQ3 2028 (Sep 2028) | 3.0869 | -- | 2.90198 | 3.29872 | 10 |
| FQ2 2028 (Jun 2028) | 2.7638 | -- | 2.59823 | 2.95345 | 10 |
| FQ1 2028 (Mar 2028) | 2.51875 | -- | 2.36786 | 2.69159 | 18 |
| FQ4 2027 (Dec 2027) | 2.83749 | -- | 2.66751 | 3.0322 | 10 |
| FQ3 2027 (Sep 2027) | 2.07323 | -- | 1.92322 | 2.16863 | 22 |
| FQ2 2027 (Jun 2027) | 1.84831 | -- | 1.71458 | 1.93336 | 11 |
| FQ1 2027 (Mar 2027) | 1.53261 | -- | 1.46255 | 1.55461 | 24 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 21.99B | -- | 20.98B | 23.15B | 8 |
| FQ3 2028 (Sep 2028) | 20.92B | -- | 19.95B | 22.02B | 8 |
| FQ2 2028 (Jun 2028) | 18.85B | -- | 17.98B | 19.84B | 8 |
| FQ1 2028 (Mar 2028) | 17.52B | -- | 16.71B | 18.44B | 11 |
| FQ4 2027 (Dec 2027) | 16.72B | -- | 15.95B | 17.6B | 13 |
| FQ3 2027 (Sep 2027) | 12.9B | -- | 12.19B | 13.36B | 23 |
| FQ2 2027 (Jun 2027) | 11.68B | -- | 11.03B | 12.09B | 12 |
| FQ1 2027 (Mar 2027) | 10.04B | -- | 9.69B | 10.15B | 17 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.76 | 0.76 | 100% | |
| FQ2 2025 (Jun 2025) | 0.54 | 0.54 | 100% | |
| FQ1 2025 (Mar 2025) | 0.44 | 0.44 | 100% | |
| FQ4 2024 (Dec 2024) | 0.3 | 0.3 | 100% | |
| FQ3 2024 (Sep 2024) | 0.48 | 0.48 | 100% | |
| FQ2 2024 (Jun 2024) | 0.16 | 0.16 | 100% | |
| FQ1 2024 (Mar 2024) | 0.0761 | 0.0761 | 100% | |
| FQ4 2023 (Dec 2023) | 0.41 | 0.41 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $9.25B | $9246M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $7.69B | $7685M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $7.44B | $7438M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $7.66B | $7658M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $6.82B | $6819M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $5.84B | $5835M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $5.47B | $5473M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $6.17B | $6168M | 100% |